Medications in Post-Acute and Long-Term Care: Challenges and Controversies
- 27 November 2020
- journal article
- editorial
- Published by Elsevier BV in Journal of the American Medical Directors Association
- Vol. 22 (1), 1-5
- https://doi.org/10.1016/j.jamda.2020.11.027
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Prevalence and Factors Associated With Polypharmacy in Long-Term Care Facilities: A Systematic ReviewJournal of the American Medical Directors Association, 2015
- STOPP/START criteria for potentially inappropriate prescribing in older people: version 2Age and Ageing, 2014
- The PREDICT (increasing the participation of the elderly in clinical trials) study: the charter and beyondExpert Review of Clinical Pharmacology, 2014
- Prescription Drug Use Among Older Adults in Italy: A Country-Wide PerspectiveJournal of the American Medical Directors Association, 2014
- Decision Making About Change of Medication for Comorbid Disease at the End of Life: An Integrative ReviewDrugs & Aging, 2014
- Medication Errors During Patient Transitions into Nursing Homes: Characteristics and Association With Patient HarmThe American Journal of Geriatric Pharmacotherapy, 2011
- Polypharmacy in nursing home residents in the United States: Results of the 2004 National Nursing Home SurveyThe American Journal of Geriatric Pharmacotherapy, 2010
- “I Just Take What I Am Given”Drugs & Aging, 2009
- Explicit Criteria for Determining Inappropriate Medication Use in Nursing Home ResidentsArchives of Internal Medicine, 1991
- Drug Prescribing by Telephone: A Potential Cause of Polypharmacy in Nursing HomesJournal of the American Geriatrics Society, 1988